Search Results Search Sort by RelevanceMost Recent Podcast Oct 2021 Author Interview: When Should Neuroendovascular Care for Patients With Acute Stroke Be Palliative? Drs Michael Young, Robert Regenhardt, and Leonard Sokol join Ethics Talk to discuss their article, coauthored with Dr Thabele Leslie-Mazwi: "When Should Neuroendovascular Care for Patients With Acute Stroke Be Palliative?" Policy Forum Dec 2020 Guidance for Physicians Who Wish to Influence Policy Development on Determination of Death by Neurologic Criteria Michael A. Rubin, MD, MA Lobbying, maintaining diagnostic skill, participating in national societies, and contributing to robust discourse can influence practice and policy. AMA J Ethics. 2020;22(12):E1033-1037. doi: 10.1001/amajethics.2020.1033. Case and Commentary Oct 2021 When Should Neuroendovascular Care for Patients With Acute Stroke Be Palliative? Michael J. Young, MD, MPhil, Robert W. Regenhardt, MD, PhD, Leonard L. Sokol, MD, and Thabele M. Leslie-Mazwi, MD For some patients whose survival is extended by disease-modifying interventions, little guidance about clinical and ethical complexities exist. AMA J Ethics. 2021;23(10):E783-793. doi: 10.1001/amajethics.2021.783.
Podcast Oct 2021 Author Interview: When Should Neuroendovascular Care for Patients With Acute Stroke Be Palliative? Drs Michael Young, Robert Regenhardt, and Leonard Sokol join Ethics Talk to discuss their article, coauthored with Dr Thabele Leslie-Mazwi: "When Should Neuroendovascular Care for Patients With Acute Stroke Be Palliative?"
Policy Forum Dec 2020 Guidance for Physicians Who Wish to Influence Policy Development on Determination of Death by Neurologic Criteria Michael A. Rubin, MD, MA Lobbying, maintaining diagnostic skill, participating in national societies, and contributing to robust discourse can influence practice and policy. AMA J Ethics. 2020;22(12):E1033-1037. doi: 10.1001/amajethics.2020.1033.
Case and Commentary Oct 2021 When Should Neuroendovascular Care for Patients With Acute Stroke Be Palliative? Michael J. Young, MD, MPhil, Robert W. Regenhardt, MD, PhD, Leonard L. Sokol, MD, and Thabele M. Leslie-Mazwi, MD For some patients whose survival is extended by disease-modifying interventions, little guidance about clinical and ethical complexities exist. AMA J Ethics. 2021;23(10):E783-793. doi: 10.1001/amajethics.2021.783.